Literature DB >> 8122374

HIV-2 viral protein X association with the GAG p27 capsid protein.

R Horton1, P Spearman, L Ratner.   

Abstract

VPX is a 16 kDa accessory protein expressed in cells infected with HIV-2 and most SIV strains and is packaged into virus particles. In order to define the requirements for incorporation of VPX into virions, VPX and HIV-2 GAG-POL were expressed independently from a vaccinia virus-based transient expression system. Under these conditions, VPX was exported from transfected cells only when coexpressed with the HIV-2 GAG-POL plasmid. A 27 kDa protein coprecipitating with VPX was found to have an identical electrophoretic mobility as the GAG capsid protein, and reacted with an anti-GAG antiserum. Coexpression of VPX and GAG-POL resulted in virus-like particles containing both proteins, as determined by sucrose gradient analyses. Expression of VPX and HIV-2 GAG without POL gave similar results. VPX association with HIV-2 GAG p27 capsid protein was specific, since no association was found with the HIV-1 GAG p25/p24 capsid protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8122374     DOI: 10.1006/viro.1994.1144

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Interaction of human immunodeficiency virus type 2 Vpx and invariant chain.

Authors:  H A Pancio; N Vander Heyden; K Kosuri; P Cresswell; L Ratner
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  The C-terminal proline-rich tail of human immunodeficiency virus type 2 Vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells.

Authors:  H A Pancio; N Vander Heyden; L Ratner
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A) correlates with efficient lentivirus infection of monocytes.

Authors:  André Berger; Carsten Münk; Matthias Schweizer; Klaus Cichutek; Silke Schüle; Egbert Flory
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

4.  Human immunodeficiency virus type 2 Vpx-Gag interaction.

Authors:  H A Pancio; L Ratner
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm).

Authors:  M A Accola; A A Bukovsky; M S Jones; H G Göttlinger
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Nuclear export of simian immunodeficiency virus Vpx protein.

Authors:  Prabhat K Singhal; P Rajendra Kumar; Malireddi R K Subba Rao; Sundarasamy Mahalingam
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

7.  Cullin4A and cullin4B are interchangeable for HIV Vpr and Vpx action through the CRL4 ubiquitin ligase complex.

Authors:  Hamayun John Sharifi; Andrea K M Furuya; Robert M Jellinger; Michael D Nekorchuk; Carlos M C de Noronha
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

8.  Adaptation to the interferon-induced antiviral state by human and simian immunodeficiency viruses.

Authors:  Julia Bitzegeio; Marissa Sampias; Paul D Bieniasz; Theodora Hatziioannou
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles.

Authors:  Y L Lu; R P Bennett; J W Wills; R Gorelick; L Ratner
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.

Authors:  X Wu; J A Conway; J Kim; J C Kappes
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.